ELIXIRGEN THERAPEUTICS
Elixirgen Therapeutics is a biotechnology company focused on curing humanity’s ailments through stem cell biology. The company concentrates on regenerative and rejuvenative medicine, and deals with research in both basic science and in the application of the technologies it discovers and refines. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Therapeutics’ scientists to conduct research at state-of-the-art facilities. Elixirgen Therapeutics inherits all the therapy-related assets, including intellectual property, from its parent company, Elixirgen, LLC, which has been in active operation since the beginning of 2012.
ELIXIRGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.elixirgentherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(443) 869-5420
Email Addresses:
[email protected]
Total Funding:
13.98 M USD
Technology used in webpage:
SPF Google Apps For Business GoDaddy DNS Pound Sterling Japanese Yen GoDaddy
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series A - Elixirgen Therapeutics
Official Site Inspections
http://www.elixirgentherapeutics.com
- Host name: 66-135-26-202.constant.com
- IP address: 66.135.26.202
- Location: Lehi United States
- Latitude: 40.3942
- Longitude: -111.8483
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84043
More informations about "Elixirgen Therapeutics"
Elixirgen Therapeutics - Crunchbase Company Profile & Funding
Elixirgen Therapeutics is a biotechnology company focused on curing humanity’s ailments through stem cell biology. The company concentrates on regenerative and rejuvenative medicine and …See details»
Elixirgen Therapeutics, Inc. - LinkedIn
Elixirgen Therapeutics is a clinical-stage RNA therapeutics company focused on the discovery and development of innovative therapies, including cell and gene therapies.See details»
Elixirgen - Crunchbase Company Profile & Funding
Organization. Elixirgen . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Elixirgen is a biotechnology firm that uses stem cell biology …See details»
Elixirgen Therapeutics Company Profile 2024: Valuation, Funding ...
Elixirgen Therapeutics is headquartered in Baltimore, MD. What is the size of Elixirgen Therapeutics? Elixirgen Therapeutics has 13 total employees. What industry is Elixirgen …See details»
Elixirgen Therapeutics, Inc. Company Profile | Baltimore, MD ...
Find company research, competitor information, contact details & financial data for Elixirgen Therapeutics, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
Aki Ko | Elixirgen
Aki Ko has served as Chief Executive Officer and Chair of the Board of Directors since May 2017, when he co-founded the company. Previously, Mr. Ko served as Chief Operating Officer for Elixirgen, LLC, the parent company of Elixirgen …See details»
Elixirgen Therapeutics Company Profile - Craft
Elixirgen Therapeutics is a biotechnology company that develops treatments through stem cell biology. It focuses on regenerative and rejuvenative medicine. The company is engaged in …See details»
Elixirgen Therapeutics - Funding, Financials, Valuation & Investors
Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines. Search Crunchbase. Start Free Trial . Chrome …See details»
Elixirgen Therapeutics Announces Licensing Agreement for Its …
BALTIMORE, Oct. 8, 2021 — Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery and development of therapies for genetic diseases and …See details»
How Elixirgen Manufactures Hematopoietic Stem Cells At The …
Oct 9, 2024 An FDA rare pediatric disease designation recently pushed extra wind into the sails of Elixirgen Therapeutics, an RNA cell therapy company. With a Phase 1/2 trial to treat …See details»
Elixirgen Therapeutics Enters Memorandum of Understanding
Jan 26, 2023 Elixirgen Therapeutics is currently conducting a Phase 1/2 trial (NCT04211714) with lead asset, EXG-34217, an autologous cell therapy to treat patients with telomere biology …See details»
FDA Approves Elixirgen Therapeutics IND Application for Therapy …
Jun 4, 2020 Elixirgen Therapeutics, Inc. is a Baltimore-based biotechnology company co-founded by Akihiro Ko and Minoru Ko, MD, PhD, which is focused on curing humanity's …See details»
Elixirgen Therapeutics planning to begin Phase I/II Clinical Trials of ...
BALTIMORE, Sept. 1, 2020 — Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery, development and commercialization of therapies for …See details»
Elixirgen Therapeutics to Present New Data Showing
Nov 7, 2022 Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self …See details»
Elixirgen Therapeutics Announces Promising Phase 1/2 Data on …
Oct 16, 2023 A Phase 1/2 clinical trial of intradermal, controllable self-replicating RNA vaccine EXG-5003 against SARS-CoV-2. This was a double-blind, placebo-controlled Phase 1/2 trial …See details»
Elixirgen Therapeutics Presents New Clinical Data - GlobeNewswire
Dec 12, 2022 Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self …See details»
Elixirgen Therapeutics’ Innovative Approach to mRNA Therapeutics
Jun 18, 2024 Aki Ko, Co-Founder and CEO, Elixirgen Therapeutics. In the rapidly evolving biotech landscape, Elixirgen Therapeutics distinguishes itself through its clear vision and …See details»
Elixirgen Therapeutics Partners with Taisho Pharmaceutical on ...
Mar 7, 2022 Elixirgen Therapeutics, Inc. is a Baltimore-based biotechnology company which is focused on curing humanity’s ailments through innovations in cell and gene therapy and …See details»
Science spotlight: Elixirgen’s full-length dystrophin gene therapy ...
Mar 9, 2024 Elixirgen Therapeutics Inc.’s full-length version was delivered via a nanoparticle, and it restored muscular function in a mouse model of Duchenne muscular dystrophy, as …See details»